ArticleJournal of immunology research2022

The BRD4 Inhibitor dBET57 Exerts Anticancer Effects by Targeting Superenhancer-Related Genes in Neuroblastoma.

Si-Qi Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.